Skip to main content
Clinical Trials/NCT04245917
NCT04245917
Suspended
Not Applicable

Natural History Study of Mitochondrial Neurogastrointestinal Encephalomyopathy

Entrada Therapeutics, Inc.5 sites in 2 countries60 target enrollmentAugust 6, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mitochondrial Neurogastrointestinal Encephalomyopathy
Sponsor
Entrada Therapeutics, Inc.
Enrollment
60
Locations
5
Primary Endpoint
MNGIE Clinical Course
Status
Suspended
Last Updated
4 years ago